Work

In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

Year: 2005

Type: article

Source: Nuclear Medicine and Biology

DOI: 10.1016/j.nucmedbio.2004.09.007

Authors: Ludovicus Staelens, Ruth Oltenfreiter, Filip Dumont, Rikki N. Waterhouse, Katia Vandenbulcke, Peter Blanckaert, Rudi A. Dierckx, Guido Slegers

Institutions: Ghent University, Columbia University, Ghent University Hospital

Language: English

Topic: Pharmacological Receptor Mechanisms and Effects

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, National Institute of Mental Health

OpenAlex ID: W2082621430

FWCI: 0.748

Cites: 10

Cited by: 10

Related to: 10